Results 141 to 150 of about 677,925 (163)

Wee1 degradation inhibitors

2016
ROUSH WILLIAM R, RAHAIM RONALD, BIBIAN MATHIEU   +2 more
openaire   +1 more source

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2016
exaly  

WEE1 INHIBITOR AND PREPARATION AND USE THEREOF

2020
ZHU YAN, YAO JINSUO, WANG YELIU, YAN QIN, HE WEINAN, CHEN CHANGJUN, SHANG XIANXING, LI JIJUN, SUN YINGHUI, LI HONGJUAN, LU CHANG, ZHANG JIUQING, HOU DENG, ZHANG XIAOJUN, LIU QICHAO   +14 more
openaire   +2 more sources

WEE1 Kinase Inhibitor AZD1775 Induces CDK1 Kinase-Dependent Origin Firing in Unperturbed G1- and S-Phase Cells

Proceedings of the National Academy of Sciences of the United States of America, 2019
Tatiana N Moiseeva, Hatice Ülkü Osmanbeyoğlu, Christopher J Bakkenist   +2 more
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2016
exaly  

Ensemble Docking-Based Virtual Screening Toward Identifying Inhibitors Against Wee1 Kinase

Future Medicinal Chemistry, 2019
Shuqun Zhang, Zhili Zuo, Ling-Mei Kong
exaly  

COMBINATIONS OF CHK1- AND WEE1 - INHIBITORS

2018
VO ALEX, KLUCHER KEVIN, PETERSON SCOTT
openaire   +1 more source

Experimental Approaches Toward Histone Acetyltransferase Inhibitors as Therapeutics

Medical Epigenetics, 2016
exaly  

PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS WEE1 KINASE INHIBITORS

2022
GILAD OREN, VACCA JOSEPH, BROWN ERIC, GILL TINA, ROCCA STEVE   +4 more
openaire   +1 more source

A Pan-Tumor Review of the Role of Poly(Adenosine Diphosphate Ribose) Polymerase Inhibitors

Ca-A Cancer Journal for Clinicians
Jennifer K Litton, Nicolas Sayegh, Chadi Hage Chehade   +2 more
exaly